Blocking PTH1R rescued TGFBR2 protein levels in osteoblasts and overcame enzalutamide resistance in a coculture system of prostate cancer and osteoblast cells, suggesting PTH1R as a novel target to overcome enzalutamide resistance in prostate cancer bone metastasis. The gene discussed is TGFBR2; the disease is prostate cancer.